Online citations, reference lists, and bibliographies.
← Back to Search

The Effect Of Various Liposome Formulations On Insulin Penetration Across Caco-2 Cell Monolayer.

Z. Değim, N. Unal, D. Eşsiz, U. Abbasoğlu
Published 2004 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The aim of the study was to determine the penetration properties of various insulin containing liposome formulations through Caco-2 cell monolayer and to compare the in vitro test results with in vivo tests. The effect of sodium taurocholate as a penetration enhancer when it was added to the liposome formulation was also investigated. In vitro permeation experiments were performed in diffusion cells with the Caco-2 cell monolayer used as the membrane. Permeability values of various insulin containing liposome formulations through Caco-2 cells were determined (log k(insulin-solution) = -2.217 +/- 0.0723 cm.h(-1), log k(insulin-liposome) = -2.141 +/- 0.0625 cm.h(-1), log k(insulin-sodium tauroholate liposome)= -1.952 +/- 0.0623 cm.h(-1)). In vivo tests were performed in mice. Formulations were administered orally and blood glucose levels were determined and penetrations were compared with the Caco-2 cell experiment results. In conclusion, the permeability of insulin was increased across Caco-2 cell monolayer when the liposome sodium taurocholate (NaTC) formulation was used. The oral administration of insulin and NaTC incorporated liposomes significantly decreased blood glucose levels. Furthermore, it was shown that a high in vitro/in vivo correlation was observed using the Caco-2 cell monolayer model.
This paper references
Cell cultures as models for drug absorption across the intestinal mucosa.
P. Artursson (1991)
10.1016/0378-5173(94)00232-T
Drug delivery studies in Caco-2 monolayers. II. Absorption enhancer effects of lysophosphatidylcholines
L. Hovgaard (1995)
10.1016/S0939-6411(99)00026-0
Preparation of alginate gel beads containing chitosan nicotinic acid salt and the functions.
Y. Murata (1999)
10.1016/0014-5793(76)80016-6
Oral administration of insulin by encapsulation within liposomes
H. M. Patel (1976)
10.1016/S0378-5173(02)00175-8
Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats.
F. Cournarie (2002)
10.1016/S1461-5347(00)00302-3
Enhancing paracellular permeability by modulating epithelial tight junctions.
Ward (2000)
10.1016/S0168-3659(02)00414-5
Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying.
F. Quaglia (2003)
10.1016/S0378-5173(01)00920-6
Review on the systemic delivery of insulin via the ocular route.
Yung-Chi Lee (2002)
10.1211/0022357011775190
Microparticulate uptake mechanisms of in‐vitro cell culture models of the respiratory epithelium
K. Foster (2001)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.3109/03639049709149796
Human Insulin Diffusion Profile Through a Layer of Caco-2 Cells
R. Greenwood (1997)
10.1016/S0378-5173(03)00378-8
In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers.
Bumsang Kim (2003)
10.1021/JS980235X
Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
K. Iwanaga (1999)
10.1016/S0168-3659(03)00263-3
Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.
K. Surendrakumar (2003)
10.1016/S0928-0987(97)86593-1
Permeability of CACO-2 to novel d4T-monophostphate prodrugs
G. O'Leasy (1996)
10.1016/S0928-0987(02)00133-1
Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate.
F. Johansson (2002)
10.1023/A:1016245711557
Characterization of Drug Transport Through Tight-Junctional Pathway in Caco-2 Monolayer: Comparison with Isolated Rat Jejunum and Colon
Y. Tanaka (2004)



This paper is referenced by
10.1016/J.JCONREL.2006.12.022
A novel approach using functional peptides for efficient intestinal absorption of insulin.
M. Morishita (2007)
10.1208/s12249-009-9272-8
Retraction Note on: The Influence of Sodium Hyaluronate, l-Leucine and Sodium Taurocholate on the Nebulization of Aqueous Betamethasone-17-Valerate Suspensions
M. Tadros (2009)
10.1016/j.xphs.2020.01.031
Evaluation of Cytotoxicity of Self-emulsifying Formulations Containing Long-chain Lipids Using Caco-2 Cell Model: Superior Safety Profile Compared to Medium-chain Lipids.
H. H. Desai (2020)
10.1016/j.jconrel.2009.02.015
Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.
N. Kamei (2009)
10.1007/S12257-009-3058-4
Strategies for oral delivery of macromolecule drugs
J. Park (2010)
Alginate microparticles produced by spray-drying for oral insulin delivery
Kristen Bowey (2009)
10.1002/ELPS.200410288
Lipid vesicles in capillary electrophoretic techniques: Characterization of structural properties and associated membrane‐molecule interactions
Rebecca L. Owen (2005)
10.1208/s12249-008-9044-x
RETRACTED ARTICLE: The Influence of Sodium Hyaluronate, l-Leucine and Sodium Taurocholate on the Nebulization of Aqueous Betamethasone-17-Valerate Suspensions
M. Tadros (2008)
10.21007/ETD.CGHS.2008.0013
Controlled Release of Insulin and Modified Insulin from a Novel Injectable Biodegradable Gel
O. Anand (2008)
10.1533/9781908818683.219
Lipids and inorganic nanoparticles in oral insulin delivery
T. A. Sonia (2015)
10.1016/j.colsurfb.2019.110759
Catanionic nanocarriers as a potential vehicle for insulin delivery.
Soledad Stagnoli (2019)
10.2147/IJN.S19917
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation
M. Niu (2011)
10.1002/9781118462157.CH12
Liposome as efficient system for intracellular delivery of bioactive molecules
Mihaela Trif (2015)
10.1088/0957-4484/21/15/155104
In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
Y. Wang (2010)
10.1533/9781908818683.113
Oral insulin delivery – challenges and strategies
T. A. Sonia (2015)
10.1016/j.ijpharm.2010.12.005
Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.
J. Parmentier (2011)
Novas Alternativas Terapêuticas Para a Adminitração Oral da Insulina Novel therapeutic strategies for oral administration of insulin
C. Reis (2009)
10.1016/j.ijpharm.2007.12.036
In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue.
Yasuko Koda (2008)
Role of protease inhibitors in Insulin therapy of Diabetes : are these beneficial ?
(2015)
10.1142/S1793984410000109
PERSPECTIVES ON NANOPARTICULATE DELIVERY OF THERAPEUTIC PROTEINS BY ORAL ADMINISTRATION
G.M.J.P.C. Coué (2010)
10.1016/j.ejps.2014.02.010
In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.
E. Sjögren (2014)
10.1016/j.jconrel.2010.05.004
Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.
N. Kamei (2010)
10.1016/j.ejps.2016.12.018
Assessment of cell viability and permeation enhancement in presence of lipid‐based self‐emulsifying drug delivery systems using Caco‐2 cell model: Polysorbate 80 as the surfactant
P. Bu (2017)
10.1016/j.ejpb.2010.09.002
In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
J. Parmentier (2010)
10.1080/02652040512331350143
Literature alerts
(2005)
10.1016/j.ijpharm.2009.04.022
Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
Y. Chen (2009)
10.1016/j.ijpharm.2010.04.019
The effects of excipients on transporter mediated absorption.
J. Goole (2010)
10.1002/jps.24215
Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole.
J. Parmentier (2014)
10.1517/17425247.2011.547469
Lipid-based oral multiparticulate formulations – advantages, technological advances and industrial applications
Dali Shukla (2011)
10.1016/B978-0-444-62614-1.00020-X
Colloidal carriers for noninvasive delivery of insulin
N. Patil (2014)
10.1560/IJC.48.3-4.169
The Electrochemistry of Liposomes
V. Hernández (2008)
10.1007/s40005-015-0219-7
Delivery of biopharmaceuticals using combination of liposome and iontophoresis: a review
Santosh K Bashyal (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar